Skip to main content
. 2016 Oct 26;7(48):78946–78957. doi: 10.18632/oncotarget.12935

Figure 4. The mutants S100A4 decrease the tumorigenic capacity of HNSCC.

Figure 4

(A) The migration ability of OECM1-P and FaDu-P cell lines were examined as described in materials and methods (*p < 0.05; **p < 0.01; ***p < 0.001). (B) Anchorage-independent growth of S100A4-overexpressing OECM1-P and FaDu-P cell lines were analyzed (**p < 0.01; ***p < 0.001). (C) Protein level of E-cadherin, Vimentin and Actin in SAS-P by immunoblot analyses. Data are represented as mean ± SD.